ABPRO HOLDINGS INC (ABP) Stock Price, Quote, News and Overview
NASDAQ:ABP - Nasdaq - US0008471031 - Common Stock - Currency: USD
ABP Quote, Performance and Key Statistics
0.2395
-0.02 (-7.31%)
The current stock price of ABP is 0.2395 USD. In the past month the price increased by 23.01%.
ABP Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 18.78 | 351.27B | ||
| AMGN | AMGEN INC | 13.05 | 153.09B | ||
| GILD | GILEAD SCIENCES INC | 14.25 | 137.18B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.17 | 96.46B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.27 | 60.44B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 56.73B | ||
| ARGX | ARGENX SE - ADR | 72.53 | 41.15B | ||
| ONC | BEONE MEDICINES LTD-ADR | 4.66 | 32.28B | ||
| BNTX | BIONTECH SE-ADR | N/A | 26.77B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 20.85B | ||
| INSM | INSMED INC | N/A | 20.74B | ||
| NTRA | NATERA INC | N/A | 19.26B |
Related stock screener links
About ABP
Company Profile
Abpro Holdings, Inc. operates as a capital pool company. The company is headquartered in New York City, New York and currently employs 6 full-time employees. The company went IPO on 2022-01-14. The firm is advancing a pipeline of next generation antibody therapies for human epidermal growth factor receptor 2 (HER2)+cancers, non-HER2+ gastric and liver cancer, and wet age-related macular degeneration and diabetic macular edema. These antibodies are developed using the Company’s proprietary DiversImmune platform. Its two lead product candidates, ABP-102 and ABP-201, feature its next generation tetravalent antibody format (TetraBi antibody format), which binds to two different targets with two distinct binding sites per target. ABP-102 is designed to redirect a patient’s immune system to fight cancer by engaging T cells through co-targeting HER2, and CD3, T-cell co-receptor. ABP-201 is designed to block blood vessel formation and normalize damaged vessels through co-targeting VEGF and ANG-2. The company plans to develop ABP-201 to treat vascular disease of the eye, focusing on wet age-related macular degeneration (Wet AMD).
Company Info
ABPRO HOLDINGS INC
6 St Johns Lane, Floor 5
New York City NEW YORK US
Employees: 6
Phone: 12488907200
ABPRO HOLDINGS INC / ABP FAQ
What is the stock price of ABPRO HOLDINGS INC today?
The current stock price of ABP is 0.2395 USD. The price decreased by -7.31% in the last trading session.
What is the ticker symbol for ABPRO HOLDINGS INC stock?
The exchange symbol of ABPRO HOLDINGS INC is ABP and it is listed on the Nasdaq exchange.
On which exchange is ABP stock listed?
ABP stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for ABPRO HOLDINGS INC stock?
5 analysts have analysed ABP and the average price target is 2.04 USD. This implies a price increase of 751.77% is expected in the next year compared to the current price of 0.2395. Check the ABPRO HOLDINGS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ABPRO HOLDINGS INC worth?
ABPRO HOLDINGS INC (ABP) has a market capitalization of 14.56M USD. This makes ABP a Nano Cap stock.
How many employees does ABPRO HOLDINGS INC have?
ABPRO HOLDINGS INC (ABP) currently has 6 employees.
What are the support and resistance levels for ABPRO HOLDINGS INC (ABP) stock?
ABPRO HOLDINGS INC (ABP) has a support level at 0.23 and a resistance level at 0.25. Check the full technical report for a detailed analysis of ABP support and resistance levels.
Should I buy ABPRO HOLDINGS INC (ABP) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ABP, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ABP, evaluating the profitability, health, valuation and growth aspects
- ABPRO HOLDINGS INC (ABP) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ABPRO HOLDINGS INC (ABP) Sales and EPS estimates to see what analysts future expectations are.
- ABPRO HOLDINGS INC (ABP) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ABPRO HOLDINGS INC (ABP) Insider and Institutional Ownership to learn about the owners and their transactions.
- ABPRO HOLDINGS INC (ABP) Stock Chart to make your own analysis
- ABPRO HOLDINGS INC (ABP) Latest news and press-releases to stay up to date.
Does ABPRO HOLDINGS INC (ABP) stock pay dividends?
ABP does not pay a dividend.
What is the Price/Earnings (PE) ratio of ABPRO HOLDINGS INC (ABP)?
ABPRO HOLDINGS INC (ABP) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.87).
ABP Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to ABP.
ABP Financial Highlights
Over the last trailing twelve months ABP reported a non-GAAP Earnings per Share(EPS) of -0.87. The EPS decreased by -2966.01% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -396% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
ABP Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to ABP. The Buy consensus is the average rating of analysts ratings from 5 analysts.